ABSTRACT
Mutations of LAMB2 typically cause autosomal recessive Pierson syndrome, a disorder characterized by congenital nephrotic syndrome, ocular and neurologic abnormalities, but may occasionally be associated with milder or oligosymptomatic disease variants.
LAMB2 encodes the basement membrane protein laminin β2 which is incorporated in specific heterotrimeric laminin isoforms and has an expression pattern corresponding to the pattern of organ manifestations in Pierson syndrome. Herein we review all previously reported and several novel LAMB2 mutations in relation to the associated phenotype in patients from 39 unrelated families. The majority of disease-causing LAMB2 mutations are truncating, consistent with the hypothesis that loss of laminin β2
function is the molecular basis of Pierson syndrome. While truncating mutations are distributed across the entire gene, missense mutations are clearly clustered in the Nterminal LN domain, which is important for intermolecular interactions. There is an association of missense mutations and small in frame deletions with a higher mean age at onset of renal disease and with absence of neurologic abnormalities, thus suggesting that at least some of these may represent hypomorphic alleles. Nevertheless, genotype alone does not appear to explain the full range of clinical variability, and therefore hitherto unidentified modifiers are likely to exist. 
BACKGROUND
Mutations of LAMB2 (MIM# 150325), the gene encoding laminin β2, were first detected in patients who suffered from congenital nephrotic syndrome (NS) histologically presenting as diffuse mesangial sclerosis, in combination with a complex ocular maldevelopment the most impressing clinical sign of which is extreme and fixed narrowing of the pupils (microcoria) (Zenker et al., 2004a) . This unusual association was first described by Pierson et al. in 1963 (Pierson et al., 1963 , and therefore the term Pierson syndrome was coined for this disorder (MIM# 609049) (Zenker et al., 2004b) . Microcoria-congenital nephrosis syndrome is a synonym. Patients with Pierson syndrome are also at risk for severe neurodevelopmental deficits including congenital muscular weakness / myasthenia and developmental retardation (Maselli et al., 2009; Wuhl et al., 2007) . The clinical manifestations in Pierson syndrome correspond well to the defects observed in mice deficient of laminin β2, who display severe glomerular kidney disease, ocular and neurologic abnormalities (Miner et al., 2006; Noakes et al., 1995a; Noakes et al., 1995b) .
Laminins represent a group of cross-shaped heterotrimeric proteins each consisting of α, β and γ subunits joined together through a coiled coil. Laminins are indispensable basement membranes constituents with important roles in cell adhesion, proliferation, differentiation and migration (Miner and Yurchenco, 2004; Ryan et al., 1996; Tunggal et al., 2000) . Laminin-521 (consisting of α5, β2, and γ1 subunits; formerly called laminin-11) is the most common laminin isoform that contains a β2-chain (Miner and Patton, 1999 ). This isoform is specifically expressed at distinct sites such as the glomerular basement membrane, various ocular structures, and the neuromuscular system, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The human LAMB2 gene maps to chromosome band 3p21 and is composed of 32 densely packed exons spanning about 12 kb of genomic DNA (Fig. 1a) . The gene encodes a protein of 1,798 amino acids, containing the typical laminin domains: the Nterminal globular laminin domain (LN) making interactions with neighboring laminins, multiple EGF-like repeats (LE) with an interjacent second globular domain (LF) whose function is currently unknown, and a coiled coil domain (LCC) (Fig. 1b) . The most Nterminal 32 amino acids represent a cleavable signal peptide.
Although Pierson syndrome was not recognized as a separate entity before 2004, several reports on single cases and a few patient series have appeared in the years since then (Bredrup et al., 2008; Choi et al., 2008; Hasselbacher et al., 2006; Kagan et al., 2008; Maselli et al., 2009; Matejas et al., 2006; VanDeVoorde et al., 2006; Wuhl et al., 2007) , indicating that this disease had likely been overlooked before. The current literature also includes some descriptions of milder variants of the disease as well as two observations of apparent isolated infantile NS caused by homozygous or compound heterozygous mutations of LAMB2 (Choi et al., 2008; Hasselbacher et al., 2006; Kagan et al., 2008; Matejas et al., 2006) . Based on the finding of missense mutations or small in frame deletions at least on one allele in these cases in contrast to the predominance of biallelic truncating mutations in the classic Pierson syndrome, it has been proposed that the level of residual laminin β2 function/expression is the main modifier of the phenotype (Hasselbacher et al., 2006; Kagan et al., 2008) . Herein we review a total of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Tables 1, 3 , and 4. The genotype and phenotype features of patients with LAMB2 mutations are listed in Table 2 .
Mutations
Sequence changes regarded as disease-causing mutations are presented in Table 1 .
They comprise missense, nonsense, and splice site mutations, as well as small deletions and insertions, found either as homozygous or compound heterozygous sequence changes in patients affected by typical Pierson syndrome or its milder variants (Choi et al., 2008; Hinkes et al., 2007; Kagan et al., 2008; Maselli et al., 2009; Matejas et al., 2006; VanDeVoorde et al., 2006; Wuhl et al., 2007; Zenker et al., 2004a Zenker et al., , 2005 , as well as in two previously published siblings with isolated NS (Hasselbacher et al., 2006) . The 12 novel mutations were identified by automated sequencing of PCR products of genomic DNA as described previously (Zenker et al., 2004a) . All coding exons and flanking intronic regions were analyzed in each patient. Sequence changes were classified as causative mutations, if they produce a premature translational stop codon, if they affect the conserved nucleotides at the splice acceptor and donor sites, respectively, or if they delete or substitute a conserved amino acid and were observed together with a mutation on the second allele.
The majority of mutations (35 out of 49) are predicted to lead to a premature translational stop codon. These mutations include 14 nonsense, 19 frameshift, and two 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Figure S1 ) and were found either in the homozygous state or in compound heterozygosity with another bona fide mutation on the second allele (Table 2 ). All missense mutations except for two (p.L139P, p.S80R) have been reported previously (Choi et al., 2008; Hasselbacher et al., 2006; Kagan et al., 2008; Matejas et al., 2006; Zenker et al., 2004a) . None of these changes was found in over 200 controls.
Five mutations were recurrent ( Table 2) . Four of them (c.1405+1G>A, c.1477delT, c.3174_3175delTG, and c.4504delA) were found in two unrelated families each, while the mutation p.R246W was independently observed in 5 unrelated families. The remaining changes are "private mutations" observed only in single families.
Mutations creating premature stop codons are almost evenly distributed along the LAMB2 gene (Fig. 1a) . They may either lead to nonsense mediated mRNA decay or result in truncated proteins. Notably, the mutation c.5258dupA, which is predicted to (Zenker et al., 2004a) . This may be due to the fact that the C-terminus of laminin β2 is important for the proper assembly of the laminin chains. Mutant laminin β2 chains that cannot be stably assembled into a trimeric laminin complex are probably degraded (Utani et al., 1994) . Consequently, all truncating mutations known to date likely represent functional null alleles.
In contrast, missense mutations and small in frame deletions obviously cluster in the LN domain of laminin β2 (Fig. 1b) . This protein domain is critical for interacting with the LN domains of α and γ chains of neighboring laminins to form the monolayer network which represents a scaffold for basement membrane assembly (Colognato et al., 1999; Yurchenco and Cheng, 1993) . This suggests that changes of highly conserved amino acid residues in that domain might perturb laminin polymerization. However, it has also been shown that the mutation p.R246W leads to significant reduction in protein expression (Zenker et al., 2004a) . This may be due to disturbances at various stages of protein processing. Consistently, studies on a mouse model expressing the laminin β2 mutant R246Q suggested that the impact of this mutant on glomerular function stems in part from impaired laminin secretion (Cheng et al., 2008) . The missense mutation p.C321R affects one of the invariant cysteines in the first EGF-like domain, LEa1 (Fig.   1c ). As these cysteine residues form disulfide bonds that stabilize the structure of the EGF-like domains, substitution by other amino acids probably result in alteration or destabilization of protein structure. The consequences of the missense change p.L1393F affecting the LCC domain remain elusive (Hasselbacher et al., 2006) . Table 2) only one allele, a nonsense mutation (p.Q125X) was identified, while the second allele has remained undetected despite sequencing of all introns and the presumed promoter region as well as screening for larger genomic deletions (using long range PCR covering the entire gene). RT-PCR on mRNA from kidney tissue of this patient, however, showed severely reduced LAMB2 mRNA expression from the allele that was not affected by the nonsense mutation (data not shown). These findings strongly support the existence of a mutation on the second allele, which escaped the employed screening methods (maybe an inversion or translocation affecting the LAMB2 locus).
Together, these results provide clear evidence that Pierson syndrome is not heterogeneous and that LAMB2 mutation detection rate reaches 98-100% in typical cases. Table 3 lists sequence variants that likely do not lead to development of Pierson syndrome or NS. These changes were quoted as probable neutral polymorphisms because they have been found either in homozygous state in healthy controls, in compound heterozygosity together with a clearly disease causing mutation in healthy Pierson syndrome carriers, or together with two bona fide mutations in patients.
Polymorphisms
Altogether, 26 polymorphisms have been detected by sequencing of more than 200 individuals of various ethnic backgrounds (Table 3 ). Eight of them are known (predicting the change p.A1765T) was found repeatedly in both patients and healthy controls, and it was found in one family to be located on the same allele as a truncating mutation (p.Q1006NfsX144) (Matejas et al., 2006) . For evolutionary conservation of these missense variants see Supp. Figure S2 .
Sequence Variants of LAMB2 with Unknown Phenotype Effect
For nine missense variations in the LAMB2 gene and three variations located 5' to the start codon in the potential promoter region, the pathogenetic significance could not definitively be determined. These changes are listed in Table 4 . All but two of them have been found as heterozygous changes in patients with NS who lacked other typical shortened at its N-terminus. A heterozygous substitution p.H882Y was found in a healthy carrier for Pierson syndrome, who was heterozygous for the mutation p.C374X, but whether the variation p.H882Y was on the same allele could not be determined, because the affected children were not available for genetic testing (Zenker et al., 2005) . Since His-882 is relatively conserved (Supp. Figure S2 ) and we cannot absolutely exclude the possibility of two clinically significant sequence changes on the same allele, we conservatively classified p.H882Y in this category.
Haplotype Analysis of Recurrent LAMB2 Mutations
In patients harbouring the five recurrent LAMB2 mutations we determined haplotypes by genotyping 13 microsatellite markers within a range of 15 Mb flanking the LAMB2 gene Figure S3 ).
The mutation p.R246W, which has been observed in 5 unrelated families, was found on the same haplotype in three families of Portuguese origin (two from Portugal and one from Brazil), thus suggesting a founder effect in this population. However, the same mutation was also found in one family of Asian origin on a different haplotype and in a patient of African origin. Shared haplotypes were also found in two families with Slavic background (originating from Poland and the Czech Republic), who carried the mutation c.4504delA, two families of German/French ancestry (mutation: c.1477delT), and two families of Middle European origin (mutation: p.C1058X), respectively. In all cases the shared haplotypes encompassed about 5 Mb. However, the precise extent could not be determined because it is impossible to distinguish identity by descent from identity by state for individual markers.
GENOTYPE-PHENOTYPE CORRELATIONS
All individuals carrying homozygous or compound heterozygous LAMB2 mutations were affected by NS in the first decade, the vast majority in the first year of life. All but two patients (affected siblings from family 13) had ocular anomalies (Table 2) . Although an ascertainment bias cannot be excluded, the current data suggest that kidney involvement is an invariant manifestation of genetic defects of the LAMB2 gene.
However, some patients may be recognized because of their eye findings, and the renal symptoms only arrive thereafter (Bredrup et al., 2008) . As mentioned above, there is strong evidence that truncating mutations, even those creating truncations of less than (Choi et al., 2008; Hasselbacher et al., 2006) , had at least one non-truncating allele or a splice site mutation whose effect on protein expression could not be definitely determined. This may suggest that only little residual function of laminin β2 is required for an apparently normal development and maintenance of the iris muscles. Notably, those patients who presented initially with only minor or without ocular changes appear to remain at high risk of developing serious ocular complications, e.g. retinal detachment, in later infancy or childhood (Bredrup et al., 2008; Choi et al., 2008; Matejas et al., 2006) . Generally, isolated NS is rarely caused by Table 2 ) with either truncating or splice site mutations on each allele, who had a normal neurologic and cognitive development up to the age of 4-21 years (Bredrup et al., 2008; Choi et al., 2008; Wuhl et al., 2007) . In one of them, possible residual function of one allele carrying a de novo splice site mutation (c.3798-2A>C) was discussed but could not be demonstrated (Wuhl et al., 2007) . Most patients who showed a favourable neurodevelopmental outcome despite the presence of biallelic mutations predicting probable complete loss of function also had delayed onset of ESRD. This observation would be compatible with the existence of genetic modifiers that may to some extent compensate for the laminin β2 defect, thereby rescuing the neurologic deficits and ameliorating the renal phenotype. Admittedly, considering truncating mutations as functional null alleles may be an oversimplification and does not 
CLINICAL AND DIAGNOSTIC RELEVANCE
The diagnosis of Pierson syndrome is based on the recognition of the typical association of glomerular kidney disease and ocular abnormalities. In the typical cases with microcoria and early onset NS the diagnosis is obvious. Molecular testing of Considering the clinical variability of LAMB2-associated disorders, predictions on the phenotypic expression on the basis of the genotype should be made with caution.
Unfortunately, this is particularly true with respect to the possibility of relevant neurologic involvement which is an important determinant of long-term prognosis.
Within the same family, however, our current experience suggests a rather high consistency of the phenotype.
Patients with Pierson syndrome are mainly taken care of by pediatric nephrologists and ophthalmologists. There is so far no specific treatment available. Nephrectomy for the treatment of severe renal protein waste may be considered similar to the management of patients with Finnish type nephrosis (Holmberg et al., 1995) , but it should be taken into account that ESRD, which usually occurs much earlier in patients with Pierson syndrome compared to Finnish type nephrosis, will spontaneously limit protein loss.
Kidney transplantation is currently the only long-term renal treatment option. There is so far no evidence of recurrence of mesangial sclerosis in the transplant, but the number of in the absence of significant congenital ocular anomalies. High grade myopia seems to be another common feature developing in infancy and early childhood (Bredrup et al., 2008 ).
An important differential diagnosis to Pierson syndrome is the nephrosis-microcephaly syndrome (Galloway-Mowat syndrome; GMS; MIM# 251300). Microcephaly which is a key finding in GMS has also been described in some patients with Pierson syndrome (Wuhl et al., 2007) . However, in the latter microcephaly is usually not congenital, but may develop during the first year of life. Moreover, other features, such as structural brain anomalies, epilepsy, and hiatus hernia usually allow distinguishing GMS from
Pierson syndrome clinically. Notably, however, there have been a few reports on patients with GMS and ocular changes resembling the manifestations in Pierson syndrome (Mildenberger et al., 1998; Shapiro et al., 1976) . Despite the obvious clinical overlap, we have found no evidence that GMS and Pierson syndrome are allelic disorders (Dietrich et al., 2008) .
There is so far no evidence for isolated ocular anomalies or ocular plus neurologic abnormalities without kidney involvement being caused by mutations in LAMB2.
Isolated microcoria was been reported as an autosomal dominant trait (MIM# 156600).
A provisional locus has been assigned to 13q31-q32 (Rouillac et al., 1998), thus ruling out LAMB2 as the causative gene for families linked to this locus. However, genetic heterogeneity is not excluded and studies of a possible significance of LAMB2 
FUTURE PROSPECTS
Future research will be directed towards the identification of possible modifiers of the phenotype caused by laminin β2 defects. Considering that a lack of expression on the β2-chain probably leads to the expression of aberrant laminin isoforms in the basement membrane rather than the complete absence of laminin (Noakes et al., 1995b) , it is tempting to speculate that laminin β1 (or other laminin β isoforms) might to some extent be able to compensate for the lack of β2. Treatment prospects might arise from the knowledge on modifying factors. As a significant proportion of LAMB2 mutations are nonsense mutations, aminoglycosides which are known to be able to induce translational stop codon readthrough (Allamand et al., 2008; Linde et al., 2007) , and which reach high concentrations particularly in the kidney, may be evaluated as a therapeutic target in the future.
A locus-specific mutation database is available at: http://www.med.unimagdeburg.de/LAMB2mutdb.
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